H3B-6545 hydrochloride

CAS: 2052132-51-9 货号: H646906 分子式: C30H30ClF4N5O2 分子量: 604.04 PubChem CID: 124091099
有货
级别和纯度: ≥99%
别名
H3B-6545 盐酸盐
储存条件
2-8°C储存,干燥
运输条件
低温运输
★
规格
库存
价格
数量
5mg
H646906-5mg
期货 Stock Image
¥3,500.90
10mg
H646906-10mg
期货 Stock Image
¥6,000.90
50mg
H646906-50mg
期货 Stock Image
¥18,000.90
100mg
H646906-100mg
期货 Stock Image
¥30,500.90
请输入您要添加的产品数量
🧪
为什么选择此级别

提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述


H3B-6545 hydrochloride is an oral, selective estrogen receptor covalent antagonist ( SERCA ) for the research of metastatic ER-positive, HER2-negative breast cancer

In Vitro

H3B-6545 is a highly selective small molecule that potently antagonizes wild-type and mutant ERα in biochemical and cell based assays. In vitro comparisons with standard of care and other experimental agents confirm increased cell potency of H3B-6545 under continuous as well as washout treatment conditions. H3B-6545, a member of a novel class of ERα antagonists refer to as selective ER covalent antagonist (SERCA), which inactivates both wild-type and mutant ERα by targeting C530 and enforcing a unique antagonist conformation. H3B-6545 is a first-in-class selective ER covalent antagonist (SERCA). H3B-6545 inhibits ERα WT activity and growth of ERα WT -positive breast cancer lines. H3B-6545 potently inhibits ERα WT activity and suppresses proliferation of ERα WT -positive breast cancer lines. With GI 50 s of 0.3-0.4, 1.0, 0.5, 5.2, and 0.2 nM for MCF7, HCC1428, BT483, T47D and CAMA-1 cell lines. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

In vivo, once daily oral dosing of H3B-6545 shows potent activity and superior efficacy to fulvestrant in the MCF-7 xenograft model with maximal antitumor activity at doses >10x below the maximum tolerated dose in mice. In addition, H3B-6545 shows superior antitumor activity to Tamoxifen and Fulvestrant in patient derived xenograft models of estrogen receptor positive breast cancer including models carrying ERα mutations in rat and monkeys, H3B-6545 is well tolerated across a broad dose range and at exposures that significantly exceed those required for efficacy in mouse xenograft models . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:Estrogen receptor

规格

别名
H3B-6545 盐酸盐
规格或纯度
≥99%
英文名称
H3B-6545 hydrochloride
生化机理
H3B-6545 盐酸盐是一种口服、选择性雌激素受体共价拮抗剂(SERCA),用于研究ER阳性、HER2阴性的转移性乳腺癌。
储存条件
2-8°C储存,干燥
运输条件
低温运输
作用类型
拮抗剂
纯度
≥99%
名称和识别符
分子类型
小分子
IUPAC Name
(E)-N,N-dimethyl-4-[2-[5-[(Z)-4,4,4-trifluoro-1-(3-fluoro-2H-indazol-5-yl)-2-phenylbut-1-enyl]pyridin-2-yl]oxyethylamino]but-2-enamide;hydrochloride
INCHI
1S/C30H29F4N5O2.ClH/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20;/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38);1H/b9-6+,28-24-;
InChi Key
KNSVJVMDHBDKJL-XVBKFJSKSA-N
Smiles
CN(C)C(=O)C=CCNCCOC1=NC=C(C=C1)C(=C(CC(F)(F)F)C2=CC=CC=C2)C3=CC4=C(NN=C4C=C3)F.Cl
PubChem CID
分子量
604.04

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

三维结构
交互式化学结构模型





化学和物理性质
溶解性
DMSO : 83.33 mg/mL (137.95 mM; Need ultrasonic)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品的纯度是多少?
本产品的化学纯度(含量)为 ≥99%。批次的具体数值以分析证书(COA)为准。
本产品应如何储存?
请于2–8 °C、干燥条件下保存。请与干燥剂一同密封保存,本品对湿气敏感。
本产品如何运输?
本产品采用湿冰冷藏运输。收货后请立即拆包,并按上述储存条件保存。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 2052132-51-9,分子式为 C30H30ClF4N5O2,分子量为 604.04 g/mol。InChIKey KNSVJVMDHBDKJL-XVBKFJSKSA-N。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。